Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertrophic Cardiomyopathy, Obstructive”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Testing effectiveness (Phase 2)UnknownNCT01332162
What this trial is testing

CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Hospital Clinic of Barcelona 80
Not applicableStudy completedNCT04141891
What this trial is testing

Advancing Understanding of Transportation Options

Who this might be right for
Diabetic RetinopathyMacular DegenerationGlaucoma+29 more
University of Colorado, Denver 529
Not applicableActive Not RecruitingNCT06947590
What this trial is testing

Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
HCM - Hypertrophic CardiomyopathyMavacamten
Xu Liu 78
Not applicableEnrolling By InvitationNCT05100420
What this trial is testing

Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository

Who this might be right for
Hypertrophic CardiomyopathyHypertrophic Obstructive CardiomyopathyFamilial Hypertrophic Cardiomyopathy+1 more
Montreal Heart Institute 2,000
Not applicableLooking for participantsNCT07541833
What this trial is testing

Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)

Who this might be right for
Cardiomyopathy
Bristol-Myers Squibb 36
Not applicableStudy completedNCT03906734
What this trial is testing

Mitral Valve Management During Septal Myectomy

Who this might be right for
Hypertrophic Cardiomyopathy
Meshalkin Research Institute of Pathology of Circulation 48
Not applicableActive Not RecruitingNCT07107373
What this trial is testing

Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Bristol-Myers Squibb 150
Not applicableNot Yet RecruitingNCT07332767
What this trial is testing

Myocardial Energetic Restoration in the Treatment of Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
University of Manchester 20
Not applicableStudy completedNCT01631006
What this trial is testing

Effects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic CardiomyopathyObstructive Hypertrophic Cardiomyopathy
University of Sao Paulo 26
Not applicableUnknownNCT05771987
What this trial is testing

Permanent Pacing for Drug-refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Istituto Auxologico Italiano 10
Large-scale testing (Phase 3)Study completedNCT05414175
What this trial is testing

Mavacamten in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Cardiomyopathy, Hypertrophic Obstructive
Bristol-Myers Squibb 38
Large-scale testing (Phase 3)Looking for participantsNCT06481891
What this trial is testing

Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Cardiomyopathy, HypertrophicNon-obstructive Hypertrophic Cardiomyopathy
Lexicon Pharmaceuticals 500
Testing effectiveness (Phase 2)Looking for participantsNCT07023614
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc. 165
Not applicableStudy completedNCT05850026
What this trial is testing

Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!

Who this might be right for
Hypertrophic Obstructive CardiomyopathyMitral Regurgitation
Michele De Bonis 26
Not applicableUnknownNCT06031519
What this trial is testing

Impact of Liwen Procedure in Obstructive Hypertrophic Cardiomyopathy on Arrhythmias

Who this might be right for
Hypertrophic CardiomyopathyArrhythmia
Xijing Hospital 350
Not applicableUnknownNCT04230551
What this trial is testing

Reverse Remodeling After PTSMA in Severe But Asymptomatic LVOT Obstruction

Who this might be right for
HOCM, Hypertrophic Obstructive CardiomyopathyLVOTO - Left Ventricular Outflow Tract ObstructionRemodeling, Ventricular
St. Antonius Hospital 15
Testing effectiveness (Phase 2)Study completedNCT04826185
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc. 67
Not applicableLooking for participantsNCT07120776
What this trial is testing

Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy \(HOCM\)Left Ventricular Outflow Tract ObstructionMyocardial Ischaemia
University of Manchester 75
Testing effectiveness (Phase 2)Study completedNCT01447654
What this trial is testing

Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Henning Bundgaard 130
Not applicableStudy completedNCT06609382
What this trial is testing

Left Ventricular Mass Index Predicts Clinical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Changrong Nie 490
Load More Results